JPY 4585.0
(-4.18%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | - JPY | 0.0% |
2022 | - JPY | 0.0% |
2021 | - JPY | 0.0% |
2020 | - JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - JPY | 0.0% |
2023 Q2 | - JPY | 0.0% |
2023 FY | - JPY | 0.0% |
2023 Q4 | - JPY | 0.0% |
2023 Q3 | - JPY | 0.0% |
2023 Q1 | - JPY | 0.0% |
2022 FY | - JPY | 0.0% |
2022 Q3 | - JPY | 0.0% |
2022 Q4 | - JPY | 0.0% |
2021 FY | - JPY | 0.0% |
2020 FY | - JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
KOHJIN BIO CO LTD | 2.46 Billion JPY | 100.0% |
PRISM BioLab Co.,LTD | - JPY | NaN% |
GNI Group Ltd. | 3.69 Billion JPY | 100.0% |
Linical Co., Ltd. | 3 Billion JPY | 100.0% |
Trans Genic Inc. | 2.25 Billion JPY | 100.0% |
MEDINET Co., Ltd. | 2.3 Million JPY | 100.0% |
Soiken Holdings Inc. | - JPY | NaN% |
Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | 100.0% |
AnGes, Inc. | 362.67 Million JPY | 100.0% |
OncoTherapy Science, Inc. | 106.84 Million JPY | 100.0% |
Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 100.0% |
Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | 100.0% |
NanoCarrier Co., Ltd. | 1.1 Billion JPY | 100.0% |
Carna Biosciences, Inc. | 182.97 Million JPY | 100.0% |
CanBas Co., Ltd. | - JPY | NaN% |
D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | 100.0% |
RaQualia Pharma Inc. | 367.71 Million JPY | 100.0% |
Chiome Bioscience Inc. | 291 Million JPY | 100.0% |
Kidswell Bio Corporation | 2.57 Billion JPY | 100.0% |
PeptiDream Inc. | 22.79 Billion JPY | 100.0% |
Oncolys BioPharma Inc. | 315.17 Million JPY | 100.0% |
Ribomic Inc. | - JPY | NaN% |
SanBio Company Limited | 665 Million JPY | 100.0% |
Healios K.K. | 4.53 Billion JPY | 100.0% |
BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | 100.0% |
Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | 100.0% |
Delta-Fly Pharma, Inc. | - JPY | NaN% |
StemRIM | - JPY | NaN% |
CellSource Co., Ltd. | 97.54 Million JPY | 100.0% |
FunPep Company Limited | - JPY | NaN% |
Kringle Pharma, Inc. | - JPY | NaN% |
Stella Pharma Corporation | 933.3 Million JPY | 100.0% |
TMS Co., Ltd. | - JPY | NaN% |
Noile-Immune Biotech Inc. | - JPY | NaN% |
K Pharma,Inc. | - JPY | NaN% |
Takara Bio Inc. | 968 Million JPY | 100.0% |
ReproCELL Incorporated | - JPY | NaN% |
PhoenixBio Co., Ltd. | 723.93 Million JPY | 100.0% |
StemCell Institute Inc. | 8.78 Million JPY | 100.0% |
Japan Tissue Engineering Co., Ltd. | - JPY | NaN% |
CellSeed Inc. | 151.25 Million JPY | 100.0% |